Assignee
NEUROVANCE INC
US·7 granted patents·2 pending applications·42 citations·filing 2013–2017
Top patents by PatentIndex Score
9 records- 0191US9205074B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2014·Granted Dec 8, 2015·9 cites·24 claims
- 0291US8877798B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2013·Granted Nov 4, 2014·11 cites·27 claims
- 0388US9737506B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2015·Granted Aug 22, 2017·5 cites·26 claims
- 0488US9708261B2Crystalline compoundsNEUROVANCE INC·Filed 2016·Granted Jul 18, 2017·6 cites·32 claims
- 0586US9856217B2Crystalline compoundsNEUROVANCE INC·Filed 2017·Granted Jan 2, 2018·4 cites·14 claims
- 0680US9839627B2Methods of treating fragile X associated disorders, ADHD, and autism spectrum disorderNEUROVANCE INC·Filed 2014·Granted Dec 12, 2017·6 cites·20 claims
- 0776US9133159B21-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicamentsNEUROVANCE INC·Filed 2013·Granted Sep 15, 2015·1 cites·41 claims
- 0854US2014206740A1Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine NeurotransmittersNEUROVANCE INC·Filed 2013·Application pending·0 cites
- 0950US2018008575A1Methods of treating binge eating disorderNEUROVANCE INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →